1. Тель Л.З. и др.Нутрициология: учебник. – М.: Литтерра, 2018. 544 с.
2. Aagaard K., Petrosino J., Keitel W., Watson M., Katancik J., Garcia N., et al. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J. 2013;27(3):1012-22.
3. NIH HMP Working Group, Peterson J., Garges S., Giovanni M., McInnes P., Wang L., et al. The NIH Human Microbiome Project. Genome Res. 2009; 19(12): 2317-2323.
4. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science. 2005; 307(5717): 1915-1920.
5. Lederberg J. Infectious history. Science 2000; 288:287–293.
6. De Vrese M., Philippe R. Marteau. Probiotics and Prebiotics: Effects on Diarrhea. J Nutr. 2007;137:803-811.
7. Claesson M.J., Jeffery I.B., Conde S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature, 2012, 488: 178-184.
8. Huycke M. M., Gaskins H. R. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp. Biol. Med. (Maywood). 2004; 229: 586–597.
9. Isolauri E., Kalliomaki M., Laitinen K., Salminen S. Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease. Curr. Pharm. Des. 2008; 14: 1368-1375.
10. Stilling R., Dinan T., Cryan J. Microbial genes, brain&behavior - epigenetic regulation of the gut-brain axis. Genes, Brain and Behav. 2013; 13: 69-86.
11. Rieder R., Wisniewski P.J., Alderman B.L., Campbell S.C. Microbes and mental health: A review. Brain, Behavior, and Immunity. 2017,66: 9-17.
12. Proal A.D., Albert P.J., Marshall T.G. Autoimmune disease in the Human Мetagenome. In: Nelson K. (eds). Metagenomics of the Human Body. Springer, New York, NY. 2011.
13. Needell J.C., Zipris D. The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis. Curr. Diab. Rep. 2016 Oct; 16 (10): 89.
14. Boulangé C.L., Neves A.L., Chilloux J., Nicholson J.K., Dumas M-E. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016 Apr 20; 8 (1): 42.
15. Ding H.T., Taur Y., Walkup J.T. Gut Microbiota and Autism: Key Concepts and Findings. J Autism Dev Disord. 2017 Feb; 47 (2): 480-489.
16. Hiromi Shinya. The Enzyme Factor. San Francisco: Council Oak Books, 2007. 168р.
17. Уголев А.М.Трофология – новая междисциплинарная наука. // Вестник АН СССР. 1980, № 1. С. 50-68. [Ugolev A. M. food Sciences is a new interdisciplinary science. Vestnik an SSSR. 1980, no. 1. Pp. 50-68. (in Russian)]
18. Мосли М.Твой кишечник не дурак// пер. с англ. А. Толмачева. М.:РИПОЛклассик, 2018. 272 с. [Mosley M. Your gut is not a fool. Translated from the English by A. Tolmachev. Moscow, RIPOLL classic, 2018. 272 p. (in Russian)]
19. Mchiza Z.J., Steyn N.P., Hill J., Kruger A., Schönfeldt H., Nel J., et al. A review of dietary surveys in the adult South African population from 2000 to 2015. Nutrients. 2015; 7(9): 8227-8250.
20. Falony G., Joossens M., Vieira-Silva S., Wang J., Darzi Y., Faust K., et al. Population-level analysis of gut microbiome variation. Science. 2016 Apr 29; 352 (6285): 560-564.
21. Шагина В.Н., Блохина И.И., Серов И.С.Влияние кишечной микрофлоры на здоровье человека // Молодой ученый. 2019. № 28. С. 200-203.
22. Сонненбург Д., Сонненбург Э.Здоровый кишечник. Как обрести контроль над весом, настроением и самочувствием. Пер. с англ. Е. Куприяновой. М.: Манн, Иванов и Фербер, 2019. 256 с.
23. Чиркин В.И., Лазарев И.А., Ардатская М.Д.Долгосрочные эффекты препарата пищевых волокон псиллиума у пациентов с метаболическим синдромом // Клинические перспективы гастроэнтерологии, гепатологии. 2012. № 1. С. 34-42.
24. Canfora E.E., Jocken J.W., Blaak E.E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015 Oct; 11 (10): 577-591.
25. Selma M.V., Espin J.C., Tomas-Barberan F.A. Interaction between phenolics and gut microbiota: Role in human health. J. Agric. Food Chem. 2009, 57, 6485-6501.
26. Etxeberria U., Arias N., Boqué N., Macarulla M., Portillo M., Martínez J., Milagro F. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. J. Nutr. Biochem. 2015, 26, 651-660.
27. Taira T., Yamaguchi S., Takahashi A., Okazaki Y., Yamaguchi A., Sakaguchi H., Chij H. Dietary polyphenols increase fecal mucin and immunoglobulin a and ameliorate the disturbance in gut microbiota caused by a high fat diet. J. Clin. Biochem. Nutr. 2015, 57, 212-216.
28. Wang L., Zeng B., Liu Z., Liao Z., Zhong Q., Gu L., Wei H., Fang X. Green tea polyphenols modulate colonic microbiota diversity and lipid Metab. in high-fat diet treated hfa mice. J. Food Sci. 2018, 83, 864-873.
29. Raninen K., et al. Dietary Fiber Type Reflects Physiological Functionality: Comparison of Grain Fiber, Inulin, and Polydextrose. Nutr. Rev. 2011. 69.1: 9-21.
30. Koeth R.A., et al. Intestinal Microbiota Metabolism of L-Carnitine, a Nutrient in Red Meat, Promotes Atherosclerosis. Nat Med. 2013. 19.5: 576-585.
31. Drouin-Chartier J.P., et al. Systematic review of the association between dairy product consumption and risk of cardiovascular-related clinical outcomes. Advances in Nutrition. 2016. Vol. 7(6). P. 1026-1040.
32. Díaz-López A., et al. Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk. European Journal of Nutrition. 2016. Vol. 55(1). P. 349-360.
33. Yu E., Hu F.B. Dairy Products, dairy fatty acids, and the prevention of cardiometabolic disease: a review of recent evidence. Current Atherosclerosis Report. 2018. Vol. 20(5). 24.
34. Drouin-Chartier J.P., et al. Systematic review of the association between dairy product consumption and risk of cardiovascular-related clinical outcomes. Advances in Nutrition. 2016. Vol. 7(6). P. 1026-1040.
35. Blottiere H.M., Buecher B., Galmiche J.P., Cherbut C. Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation. Proc. Nutr. Soc. 2003; 62 (1): 101-106.
36. Evangelos C. Rizos, Evangelia E. Ntzani, Eftychia Bika, et al. Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events: а Systematic Review and Meta-analysis. JAMA. 2012. 308(10):1024-1033.
37. Park K.Y., Jeong J.K., Lee Y.E., Daily J.W. Health benefits of kimchi (Korean fermented vegetables) as a probiotic food. Journal of Medicinal Food. 2014. Vol. 17. P. 6-20.
38. An S.Y., et al. Beneficial effects of fresh and fermented kimchi in prediabetic individuals. Annals of Nutrition and Metabolism. 2013. Vol. 63. P. 111-119. DOI: 10.1159/000353583.
39. David Zeevi, et al. Personalized Nutrition by Prediction of Glycemic Response. Cell. 2015, 163, 1079-1094.
40. Morgan X.C., et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012. 13: 76-79
41. Versalovic J. The Human Microbiome and Probiotics: Implications for Pediatrics. Ann Nutr Metab. 2013. 63 (Suppl. 2): 42-52.
42. Ley R.E., Lozupone C., Hamady M., Knight R., Gordon J.I. Worlds within worlds: evolution of the vertebrate gut microbiota. Nature Rev Microbiol. 2008. Vol.6. P. 776-88.
English
Русский
